Jaguar Health (JAGX) Cash from Operations Growth (3y) (2017 - 2026)
Jaguar Health (JAGX) Cash from Operations Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
42.41% |
| Date | Value |
|---|
| Mar 31, 2026 |
42.41% |
| Dec 31, 2025 |
5.11% |
| Sep 30, 2025 |
18.08% |
| Jun 30, 2025 |
16.01% |
| Mar 31, 2025 |
1.68% |
| Dec 31, 2024 |
4.28% |
| Sep 30, 2024 |
12.40% |
| Jun 30, 2024 |
6.22% |
| Mar 31, 2024 |
-1.66% |
| Dec 31, 2023 |
-22.42% |
| Sep 30, 2023 |
-32.50% |
| Jun 30, 2023 |
-31.29% |
| Mar 31, 2023 |
-32.29% |
| Dec 31, 2022 |
-26.94% |
| Sep 30, 2022 |
0.07% |
| Jun 30, 2022 |
-25.38% |
| Mar 31, 2022 |
-30.47% |
| Dec 31, 2021 |
-22.10% |
| Sep 30, 2021 |
-49.72% |
| Jun 30, 2021 |
-22.44% |
